{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:06:08Z","timestamp":1790805968508,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.coviro.2021.03.009","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T13:50:42Z","timestamp":1617717042000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Animal models for SARS-CoV-2"],"prefix":"10.1016","volume":"48","author":[{"given":"Chung-Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anice C","family":"Lowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2021.03.009_bib0005","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"key":"10.1016\/j.coviro.2021.03.009_bib0010","series-title":"COVID-19 Weekly Epidemiological Update","author":"WHO","year":"2020"},{"key":"10.1016\/j.coviro.2021.03.009_bib0015","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s40265-020-01378-w","article-title":"Remdesivir: first approval","volume":"80","author":"Lamb","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.coviro.2021.03.009_bib0020","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1056\/NEJMp2030646","article-title":"Medicaid and child health equity","volume":"383","author":"Perrin","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2021.03.009_bib0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2021.03.009_bib0030","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2021.03.009_bib0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virol.2004.09.030","article-title":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys","volume":"330","author":"McAuliffe","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2021.03.009_bib0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/JVI.79.1.503-511.2005","article-title":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters","volume":"79","author":"Roberts","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.03.009_sbref0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2021.03.009_bib0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2021.03.009_bib0055","doi-asserted-by":"crossref","first-page":"16587","DOI":"10.1073\/pnas.2009799117","article-title":"Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development","volume":"117","author":"Imai","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.03.009_sbref0060","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","article-title":"Pathogenesis and transmission of SARS-CoV-2 in golden hamsters","volume":"583","author":"Sia","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_sbref0065","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41392-020-00269-6","article-title":"Comparison of nonhuman primates identified the suitable model for COVID-19","volume":"5","author":"Lu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.coviro.2021.03.009_sbref0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-020-2324-7","article-title":"Respiratory disease in rhesus macaques inoculated with SARS-CoV-2","volume":"585","author":"Munster","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_bib0080","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41422-020-0364-z","article-title":"Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in rhesus macaques","volume":"30","author":"Shan","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.coviro.2021.03.009_bib0085","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41590-020-00835-8","article-title":"Establishment of an African green monkey model for COVID-19 and protection against re-infection","volume":"22","author":"Woolsey","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cell.2020.05.027","article-title":"Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2","volume":"182","author":"Jiang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2021.03.009_bib0095","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","article-title":"A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice","volume":"183","author":"Leist","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2021.03.009_bib0100","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1128\/JVI.78.20.11416-11421.2004","article-title":"Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1","volume":"78","author":"Hogan","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0105","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1128\/JVI.79.9.5833-5838.2005","article-title":"Aged BALB\/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans","volume":"79","author":"Roberts","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tim.2006.05.007","article-title":"Is there an ideal animal model for SARS?","volume":"14","author":"Subbarao","year":"2006","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.virol.2009.09.023","article-title":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo","volume":"395","author":"Day","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2021.03.009_bib0120","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0125","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1371\/journal.ppat.0030005","article-title":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB\/c mice","volume":"3","author":"Roberts","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.03.009_bib0130","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/JVI.01702-06","article-title":"Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor","volume":"81","author":"Tseng","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0135","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142032","article-title":"Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease","volume":"5","author":"Golden","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.coviro.2021.03.009_bib0145","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","volume":"21","author":"Winkler","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0150","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1080\/22221751.2020.1838955","article-title":"Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection","volume":"9","author":"Rathnasinghe","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.coviro.2021.03.009_sbref0155","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","article-title":"A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures","volume":"586","author":"Dinnon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_bib0160","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cell.2020.06.010","article-title":"Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment","volume":"182","author":"Sun","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2021.03.009_bib0165","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cell.2020.06.011","article-title":"A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies","volume":"182","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2021.03.009_bib0170","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201241","article-title":"Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling","volume":"217","author":"Israelow","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2021.03.009_bib0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1165\/rcmb.2020-0354OC","article-title":"Lung expression of human angiotensin-converting enzyme 2 sensitizes the mouse to SARS-CoV-2 infection","volume":"64","author":"Han","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0180","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","article-title":"A mouse model of SARS-CoV-2 infection and pathogenesis","volume":"28","author":"Sun","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2021.03.009_bib0185","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.abc4730","article-title":"Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy","volume":"369","author":"Gu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.03.009_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107940","article-title":"Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice","volume":"32","author":"Pruijssers","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2021.03.009_bib0195","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s13238-020-00767-x","article-title":"Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB\/c and C57BL\/6J mice","volume":"11","author":"Wang","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.coviro.2021.03.009_bib0200","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_bib0205","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201993","article-title":"Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo","volume":"218","author":"Schafer","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2021.03.009_bib0210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_bib0215","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4049\/jimmunol.2000583","article-title":"A potently neutralizing antibody protects mice against SARS-CoV-2 infection","volume":"205","author":"Alsoussi","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.03.009_bib0225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.medj.2020.12.006","article-title":"A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice","volume":"2","author":"Silva-Cayetano","year":"2020","journal-title":"Med"},{"key":"10.1016\/j.coviro.2021.03.009_bib0230","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_bib0235","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41392-020-00402-5","article-title":"RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response","volume":"5","author":"Liu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.coviro.2021.03.009_sbref0240","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_bib0245","article-title":"A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.03.009_bib0250","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","article-title":"Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2021.03.009_bib0255","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice","volume":"12","author":"Tian","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.03.009_bib0260","article-title":"A Newcastle Disease Virus (NDV) expressing a membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine","volume":"8","author":"Sun","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.coviro.2021.03.009_bib0265","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.3389\/fimmu.2019.02329","article-title":"Syrian hamster as an animal model for the study on infectious diseases","volume":"10","author":"Miao","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2021.03.009_sbref0270","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","article-title":"Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility","volume":"71","author":"Chan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2021.03.009_bib0275","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1080\/22221751.2020.1858177","article-title":"Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection","volume":"9","author":"Rosenke","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.coviro.2021.03.009_bib0280","article-title":"SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters","author":"Zhang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2021.03.009_bib0285","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.cmi.2020.05.017","article-title":"Anosmia in COVID-19 patients","volume":"26","author":"Hornuss","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.coviro.2021.03.009_bib0290","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.medmal.2020.04.006","article-title":"Features of anosmia in COVID-19","volume":"50","author":"Klopfenstein","year":"2020","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.coviro.2021.03.009_sbref0295","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.abe8499","article-title":"SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo","volume":"370","author":"Hou","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.03.009_bib0300","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143174","article-title":"Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models","volume":"5","author":"Rosenke","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.coviro.2021.03.009_bib0305","doi-asserted-by":"crossref","first-page":"26955","DOI":"10.1073\/pnas.2014441117","article-title":"Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity","volume":"117","author":"Kaptein","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.03.009_bib0310","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41564-020-00802-x","article-title":"Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters","volume":"5","author":"Yuan","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0315","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.abe0075","article-title":"De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2","volume":"370","author":"Linsky","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.03.009_bib0320","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.abe3354","article-title":"Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms","volume":"370","author":"Tortorici","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.03.009_bib0325","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.03.009_bib0330","doi-asserted-by":"crossref","first-page":"29832","DOI":"10.1073\/pnas.2010197117","article-title":"Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection","volume":"117","author":"Li","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2021.03.009_bib0335","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cell.2020.09.049","article-title":"A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model","volume":"183","author":"Kreye","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2021.03.009_bib0340","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2020.09.035","article-title":"Structurally resolved SARS-CoV-2 antibody shows high efficacy in severely infected hamsters and provides a potent cocktail pairing strategy","volume":"183","author":"Du","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2021.03.009_bib0345","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1126\/science.abe2402","article-title":"REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters","volume":"370","author":"Baum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.03.009_bib0350","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/s41591-020-1070-6","article-title":"Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters","volume":"26","author":"Tostanoski","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2021.03.009_bib0355","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2353\/ajpath.2007.070248","article-title":"Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals","volume":"171","author":"van Riel","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0360","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/v20801530","article-title":"Animal models for influenza virus pathogenesis and transmission","volume":"2","author":"Bouvier","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2021.03.009_bib0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virol.2007.12.032","article-title":"The SARS-CoV ferret model in an infection-challenge study","volume":"374","author":"Chu","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2021.03.009_bib0370","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/425915a","article-title":"SARS virus infection of cats and ferrets","volume":"425","author":"Martina","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_bib0375","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.03.009_sbref0380","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.chom.2020.03.023","article-title":"Infection and rapid transmission of SARS-CoV-2 in ferrets","volume":"27","author":"Kim","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2021.03.009_bib0385","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S2666-5247(20)30089-6","article-title":"SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study","volume":"1","author":"Schlottau","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.coviro.2021.03.009_bib0390","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41467-020-20439-y","article-title":"Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity","volume":"12","author":"Ryan","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.03.009_bib0395","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02232-20","article-title":"Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1\/2020 reference isolate","author":"Patel","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0400","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01114-20","article-title":"Antiviral efficacies of FDA-approved drugs against SARS-CoV-2 infection in ferrets","volume":"11","author":"Park","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.coviro.2021.03.009_bib0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41564-020-00835-2","article-title":"Therapeutically administered ribonucleoside analogue MK-4482\/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets","volume":"6","author":"Cox","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0410","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.coviro.2013.01.001","article-title":"Animal models for highly pathogenic emerging viruses","volume":"3","author":"Safronetz","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0415","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00940-20","article-title":"Broad and differential animal angiotensin-converting enzyme 2 receptor usage by SARS-CoV-2","volume":"94","author":"Zhao","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0420","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.abc4776","article-title":"SARS-CoV-2 infection protects against rechallenge in rhesus macaques","volume":"369","author":"Chandrashekar","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.03.009_bib0425","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1126\/science.abb7314","article-title":"Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model","volume":"368","author":"Rockx","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.03.009_bib0430","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12985-020-01396-w","article-title":"Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase","volume":"17","author":"Cross","year":"2020","journal-title":"Virol J"},{"key":"10.1016\/j.coviro.2021.03.009_bib0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008903","article-title":"SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET\/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts","volume":"16","author":"Hartman","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.03.009_bib0440","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ajpath.2020.10.016","article-title":"Acute respiratory distress in aged, SARS-CoV-2-infected African green monkeys but not rhesus macaques","volume":"191","author":"Blair","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.coviro.2021.03.009_sbref0445","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ame2.12108","article-title":"Age-related rhesus macaque models of COVID-19","volume":"3","author":"Yu","year":"2020","journal-title":"Anim Model Exp Med"},{"key":"10.1016\/j.coviro.2021.03.009_bib0450","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_bib0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008949","article-title":"Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: a nonhuman primate model of COVID-19 progression","volume":"16","author":"Zheng","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2021.03.009_bib0460","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19967-4","article-title":"Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates","volume":"11","author":"Fahlberg","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.03.009_bib0465","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","volume":"586","author":"Mercado","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_bib0470","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18077-5","article-title":"An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques","volume":"11","author":"Feng","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2021.03.009_bib0475","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.03.009_bib0480","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2021.03.009_bib0485","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1016\/j.vaccine.2020.10.064","article-title":"NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge","volume":"38","author":"Guebre-Xabier","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2021.03.009_bib0490","doi-asserted-by":"crossref","DOI":"10.3390\/v12070779","article-title":"Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters","volume":"12","author":"Osterrieder","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2021.03.009_bib0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103132","article-title":"Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate","volume":"62","author":"Sun","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coviro.2021.03.009_bib0500","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.abc5881","article-title":"Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody","volume":"369","author":"Lv","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coviro.2021.03.009_sbref0505","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-2423-5","article-title":"Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2","volume":"585","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2021.03.009_bib0510","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s42003-020-01370-w","article-title":"Comparative ACE2 variation and primate COVID-19 risk","volume":"3","author":"Melin","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.coviro.2021.03.009_bib0515","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41586-020-2558-4","article-title":"Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates","volume":"585","author":"Maisonnasse","year":"2020","journal-title":"Nature"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625721000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625721000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:05:14Z","timestamp":1761818714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625721000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":103,"alternative-id":["S1879625721000316"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2021.03.009","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models for SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2021.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}